Daniel Barber
2023
In 2023, Daniel Barber earned a total compensation of $2.5M as Chief Executive Officer at Aquestive Therapeutics, a 88% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $435,600 |
|---|---|
| Salary | $600,000 |
| Stock Awards | $1,432,635 |
| Other | $27,906 |
| Total | $2,496,141 |
Barber received $1.4M in stock awards, accounting for 57% of the total pay in 2023.
Barber also received $435.6K in non-equity incentive plan, $600K in salary and $27.9K in other compensation.
Rankings
In 2023, Daniel Barber's compensation ranked 365th out of 2,309 executives tracked by ExecPay. In other words, Barber earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 365 out of 2,309 | 84th |
Division Manufacturing | 205 out of 1,247 | 84th |
Major group Chemicals And Allied Products | 143 out of 705 | 80th |
Industry group Drugs | 141 out of 676 | 79th |
Industry Pharmaceutical Preparations | 89 out of 490 | 82nd |
Source: SEC filing on April 26, 2024.
Barber's colleagues
We found two more compensation records of executives who worked with Daniel Barber at Aquestive Therapeutics in 2023.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020